GHRP-2 5mg Beligas

£40.00

GHRP-2 5mg Beligas is a synthetic growth hormone releasing peptide specifically designed for rigorous in-vitro laboratory research applications investigating growth hormone secretion pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
GHRP-2 5mg Beligas
GHRP-2 5mg Beligas
£40.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research-Grade GHRP-2 for Laboratory Studies

GHRP-2 is a synthetic hexapeptide belonging to the growth hormone releasing peptide family, engineered to investigate growth hormone secretagogue mechanisms in controlled laboratory environments. This research peptide demonstrates high binding affinity to growth hormone secretagogue receptors (GHSR) in preclinical models, making it a valuable tool for studying pituitary function and growth hormone axis modulation. Researchers at Stroid UK Shop can examine how this peptide interacts with hypothalamic-pituitary signalling pathways in cellular and tissue-based assays.

Laboratory Research Applications

Scientists study GHRP-2 to analyse growth hormone release mechanisms and investigate potential therapeutic targets for growth hormone deficiency models. The peptide’s selectivity for GHSR makes it particularly useful for researchers examining the relationship between growth hormone secretagogues and metabolic processes in laboratory settings. Research teams investigating peptides often utilise GHRP-2 alongside other growth hormone releasing compounds to understand receptor specificity and downstream signalling cascades. Academic institutions and pharmaceutical laboratories frequently incorporate this peptide into studies examining growth hormone pulsatility patterns and receptor pharmacology. The synthetic nature of GHRP-2 allows for consistent experimental conditions when researchers evaluate dose-response relationships in controlled laboratory environments. Studies investigating the peptide’s stability and bioactivity contribute to understanding optimal storage and handling protocols for research applications. Scientists also examine GHRP-2’s potential interactions with other growth hormone modulators, providing insights into combination effects in experimental models. Researchers exploring SARMs may study concurrent pathways affected by growth hormone signalling to understand broader metabolic implications.

Product Specifications

GHRP-2 5mg Beligas Technical Data
Parameter Specification
Chemical Name Growth Hormone Releasing Peptide-2
Sequence H-D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2
Molecular Formula C45H55N9O6
Molecular Weight 817.97 g/mol
CAS Number 158861-67-7
Purity ≥98% (HPLC)
Form Lyophilised powder
Storage -20°C (lyophilised), 2-8°C (reconstituted)

This Beligas formulation provides researchers with consistent quality for reproducible experimental results when investigating growth hormone releasing mechanisms in laboratory studies.

Research Compliance and Safety

GHRP-2 5mg Beligas is intended strictly for in-vitro research purposes only and is not approved for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and comply with institutional guidelines when handling this research peptide. This product is designed for qualified scientists conducting legitimate research in properly equipped laboratory facilities. Studies involving GHRP-2 peptides should be conducted by trained personnel familiar with peptide handling procedures and safety requirements for research-grade biochemical compounds.

Related